// App-Quantinova.ai

1239P : Validating prognostic models in metastatic uveal melanoma (MUM), an international rare cancers initiative

Researchers

Presenter

  • L.Khoja

Principal Investigators

  • E.Atenafu

  • A.M.Joshua

Medical Centers

  • Clinical Development Unit, AstraZeneca plc, Melbourn, UK

  • University of Toronto, Toronto, ON, Canada

  • Medical Oncology, Kinghorn Cancer Centre, Sydney, Australia

  • Cancer Research UK, International Rare Cancers Initiative, London, UK

Locations

  • United Kingdom

  • Canada

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved